Sort
141,003 grants matching “cytokine”
A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease
$2,494,955Howard Feldman · University Of California, San Diego · R01 · FY2023 · AG
Pathophysiology of Acute Pain in Patients with Sickle Cell Disease
$2,494,416Swee Lay Thein · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,492,476Christopher K Glass · University Of California, San Diego · P01 · FY2023 · HL
Senescent cell mapping, identification and validation for human somatic and reproductive tissues
$2,492,316Judith Campisi · Buck Institute For Research On Aging · U54 · FY2022 · AG
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$2,490,943Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2020 · CA
HPMI: Host Pathogen Mapping Initiative
$2,489,172Nevan J Krogan · University Of California, San Francisco · U19 · FY2023 · AI
Protection of Ischemic Myocardium
$2,488,563Roberto Bolli · University Of Louisville · P01 · FY2015 · HL
Molecular Targeting of Developmental Cancers in Children
$2,487,338Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2006 · CA
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,486,098Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Transfusion and Lung Injury
$2,486,078Pearl T Toy · University Of California, San Francisco · P50 · FY2006 · HL
The Role of Inflammation in Cardiovascular Disease
$2,485,571David G Harrison · Vanderbilt University Medical Center · P01 · FY2016 · HL
SPORE in Lymphoma
$2,485,217Richard F. Ambinder · Johns Hopkins University · P50 · FY2006 · CA
Mechanisms of mitigation of radiation damage of GI tract by Protectan CBLB502
$2,485,184Andrei V Gudkov · Cleveland Biolabs, Inc. · RC2 · FY2010 · AI
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$2,483,786Rachel R. Caspi · National Eye Institute · ZIA · FY2012 · EY
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$2,482,115Rachel R. Caspi · National Eye Institute · ZIA · FY2013 · EY
SPORE in Lymphoma
$2,482,109Johns Hopkins University · P50 · FY2003 · CA
Ecopathogenomics of sexually transmitted infections (EPSTI)
$2,479,885Patrik M Bavoil · University Of Maryland Baltimore · U19 · FY2014 · AI
Endothelial Dysfunction and Restoration in Trauma Induced Coagulopathy
$2,479,484Matthew D Neal · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · HL
ETIB Clinical Research Core
$2,479,411Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2011 · CA
PD-1 Function, Signaling, and Regulation During Viral Infection
$2,478,914Rafi Ahmed · Emory University · P01 · FY2009 · AI
Combination Therapies to Defeat Melanoma Resistance
$2,478,520Antoni Ribas · University Of California Los Angeles · P01 · FY2024 · CA
TAS::75 0885::TAS NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$2,477,572Norman L Letvin · Beth Israel Deaconess Medical Center · N01 · FY2010 · AI
HPMI: Host Pathogen Mapping Initiative
$2,475,950Nevan J Krogan · University Of California, San Francisco · U19 · FY2024 · AI
The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis
$2,474,858William G Stetler-Stevenson · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Reagent Resource Support Program for AIDS Vaccine Development
$2,474,435Ronald Brown · Quality Biological, Inc. · N01 · FY2013 · AI